• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

XGBoost Classifies Non-Small Cell Lung Cancer Staging Using Routine Laboratory Parameters

by
November 16, 2026
in Biology
Reading Time: 2 mins read
0
XGBoost Classifies Non-Small Cell Lung Cancer Staging Using Routine Laboratory Parameters

XGBoost Classifies Non-Small Cell Lung Cancer Staging Using Routine Laboratory Parameters

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

An eXtreme Gradient Boosting machine learning model developed using routine pre-treatment laboratory parameters achieved reliable discrimination between early-stage and advanced-stage non-small cell lung cancer, reaching an area under the receiver operating characteristic curve of 0.875 in a validation cohort.

Non-small cell lung cancer is one of the most prevalent malignancies worldwide, and the clinical stage identified at diagnosis guides treatment strategies and strongly influences clinical outcomes. To investigate whether routine clinical data could assist in this classification, researchers evaluated whether computational models could distinguish early from advanced disease using routinely collected tests.

The retrospective study included 1,240 patients with pathologically confirmed non-small cell lung cancer. Before treatment commenced, sixty-seven laboratory parameters and three clinical variables were collected for each participant.

The patient cohort was randomly divided into a training set comprising 70 percent of the sample and a validation set comprising 30 percent. Investigators constructed two predictive architectures—an eXtreme Gradient Boosting model and a logistic regression model—to differentiate early-stage disease, defined as TNM stages I to II, from advanced-stage disease, defined as TNM stages III to IV.

Model performance was evaluated using receiver operating characteristic curves, bootstrap resampling, and decision curve analysis. In the validation cohort, the eXtreme Gradient Boosting model achieved a significantly higher area under the curve than the logistic regression model, registering 0.875 compared to 0.834 via the DeLong test with a p-value of 0.0061, while also demonstrating higher specificity and accuracy.

Interpretability evaluated through SHapley Additive exPlanations identified carcinoembryonic antigen, sialic acid, and fibrinogen as the most influential predictors in the model. Additionally, decision curve analysis indicated that the gradient boosting framework delivered a net clinical benefit across a range of clinically relevant threshold probabilities.

Subgroup analyses showed strong discriminative performance of the eXtreme Gradient Boosting model in patients with adenocarcinoma, whereas both the gradient boosting and logistic regression models showed limited discrimination in squamous cell carcinoma. The authors concluded that the model based primarily on routine laboratory parameters provides good discrimination for staging and may serve as a noninvasive adjunct for preliminary risk stratification.

Subject of Research: Machine learning classification for non-small cell lung cancer staging using routine laboratory parameters

Article Title: Machine learning-assisted staging classification of non-small cell lung cancer using routine laboratory parameters

Article References: Mu, Y., Zhu, Y., Zhao, C., li, K., li, Y., sun, C., xiao, C., & Li, G. (2026). Machine learning-assisted staging classification of non-small cell lung cancer using routine laboratory parameters. Frontiers in Molecular Biosciences, 13, 1999345. https://doi.org/10.3389/fmolb.2026.1999345

Image Credits: AI Generated

DOI: 10.3389/fmolb.2026.1999345

Keywords: non-small cell lung cancer, XGBoost, routine laboratory parameters, TNM staging, machine learning, carcinoembryonic antigen, sialic acid, fibrinogen, logistic regression, adenocarcinoma, squamous cell carcinoma, SHAP analysis, decision curve analysis, receiver operating characteristic, area under the curve, risk stratification

News Source: Nathaniel Bowman. (November 16, 2026). XGBoost Classifies Non-Small Cell Lung Cancer Staging Using Routine Laboratory Parameters. Scienmag.

Tags: adenocarcinomaarea under the curveCarcinoembryonic Antigendecision curve analysisfibrinogenlogistic regressionMachine Learningnon-small cell lung cancerreceiver operating characteristicrisk stratificationroutine laboratory parametersSHAP analysissialic acidsquamous cell carcinomaTNM stagingXGBoost
Share12Tweet7Share2ShareShareShare1

Related Posts

Road Scat Surveys Reveal South Texas Bobcats but Miss Sympatric Ocelots

Road Scat Surveys Reveal South Texas Bobcats but Miss Sympatric Ocelots

November 16, 2026
Internal Body States Shape Fear Memory Retrieval and Extinction Renewal

Internal Body States Shape Fear Memory Retrieval and Extinction Renewal

November 16, 2026

M-Function Formalism Captures Chaotic Intermittency in Discrete and Continuous Neuron Models

November 16, 2026

Lizard Gut Microbiome Reveals Distinct Adaptation Drivers Beyond Diet

November 16, 2026

POPULAR NEWS

  • Audio Codecs Alter Speech Acoustics Without Impairing Emotion Recognition in Cochlear Implants

    Audio Codecs Alter Speech Acoustics Without Impairing Emotion Recognition in Cochlear Implants

    29 shares
    Share 12 Tweet 7
  • Autistic Children With Cochlear Implants Show Broadly Comparable Developmental Outcomes

    29 shares
    Share 12 Tweet 7
  • Internal Body States Shape Fear Memory Retrieval and Extinction Renewal

    29 shares
    Share 12 Tweet 7
  • Salivary Microbial Profiles Link Obstructive Sleep Apnea to Cognitive Impairment Risks

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Road Scat Surveys Reveal South Texas Bobcats but Miss Sympatric Ocelots

Audio Codecs Alter Speech Acoustics Without Impairing Emotion Recognition in Cochlear Implants

Autistic Children With Cochlear Implants Show Broadly Comparable Developmental Outcomes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.